145 related articles for article (PubMed ID: 35707363)
1. Identifying Immune Cell Infiltration and Effective Diagnostic Biomarkers in Lung Adenocarcinoma by Comprehensive Bioinformatics Analysis and
Li X; Chen X; Yuan Y; Zhai R; Cho WC; Jiang X
Front Oncol; 2022; 12():916947. PubMed ID: 35707363
[TBL] [Abstract][Full Text] [Related]
2. Long Non-Coding RNA-TMPO-AS1 as ceRNA Binding to let-7c-5p Upregulates STRIP2 Expression and Predicts Poor Prognosis in Lung Adenocarcinoma.
Wang J; Yuan Y; Tang L; Zhai H; Zhang D; Duan L; Jiang X; Li C
Front Oncol; 2022; 12():921200. PubMed ID: 35774125
[TBL] [Abstract][Full Text] [Related]
3. NcRNA-Mediated High Expression of
Jiang X; Tang L; Yuan Y; Wang J; Zhang D; Qian K; Cho WC; Duan L
Front Oncol; 2022; 12():846536. PubMed ID: 35311097
[TBL] [Abstract][Full Text] [Related]
4. Competitive endogenous RNA network identifies four long non-coding RNA signature as a candidate prognostic biomarker for lung adenocarcinoma.
Hu J; Wang T; Chen Q
Transl Cancer Res; 2019 Aug; 8(4):1046-1064. PubMed ID: 35116848
[TBL] [Abstract][Full Text] [Related]
5. Identification and Validation of lncRNA-SNHG17 in Lung Adenocarcinoma: A Novel Prognostic and Diagnostic Indicator.
Li X; Yuan Y; Pal M; Jiang X
Front Oncol; 2022; 12():929655. PubMed ID: 35719962
[TBL] [Abstract][Full Text] [Related]
6. Extra Spindle Pole Bodies-Like 1 Serves as a Prognostic Biomarker and Promotes Lung Adenocarcinoma Metastasis.
Nie Z; Pu T; Han Z; Wang C; Pan C; Li P; Ma X; Yao Y; Zhao Y; Wang C; Jiang X; Ding J
Front Oncol; 2022; 12():930647. PubMed ID: 35814478
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel prognosis-associated ceRNA network in lung adenocarcinoma via bioinformatics analysis.
Li Y; Yu X; Zhang Y; Wang X; Zhao L; Liu D; Zhao G; Gao X; Fu J; Zang A; Jia Y
Biomed Eng Online; 2021 Nov; 20(1):117. PubMed ID: 34819106
[TBL] [Abstract][Full Text] [Related]
8. Systematic Analysis and Validation of the Prognosis, Immunological Role and Biology Function of the Ferroptosis-Related lncRNA GSEC/miRNA-101-3p/CISD1 Axis in Lung Adenocarcinoma.
Jiang X; Yuan Y; Tang L; Wang J; Zhang D; Duan L
Front Mol Biosci; 2021; 8():793732. PubMed ID: 35320929
[TBL] [Abstract][Full Text] [Related]
9. LncRNA-AL035458.2/hsa-miR-181a-5p Axis-Mediated High Expression of NCAPG2 Correlates With Tumor Immune Infiltration and Non-Small Cell Lung Cancer Progression.
Chen X; Guo J; Ren W; Zhou F; Niu X; Jiang X
Front Oncol; 2022; 12():910437. PubMed ID: 35664767
[TBL] [Abstract][Full Text] [Related]
10. Construction of an immune-related lncRNA signature pair for predicting oncologic outcomes and the sensitivity of immunosuppressor in treatment of lung adenocarcinoma.
Zhuang J; Chen Z; Chen Z; Chen J; Liu M; Xu X; Liu Y; Yang S; Hu Z; He F
Respir Res; 2022 May; 23(1):123. PubMed ID: 35562727
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of an autophagy-related long non-coding RNA signature as a prognostic biomarker for patients with lung adenocarcinoma.
Jiang A; Liu N; Bai S; Wang J; Gao H; Zheng X; Fu X; Ren M; Zhang X; Tian T; Ruan Z; Liang X; Yao Y
J Thorac Dis; 2021 Feb; 13(2):720-734. PubMed ID: 33717544
[TBL] [Abstract][Full Text] [Related]
12.
Wang FM; Xu LQ; Zhang ZC; Guo Q; Du ZP; Lei Y; Han X; Wu CY; Zhao F; Chen JL
Aging (Albany NY); 2024 Jan; 16(2):1605-1619. PubMed ID: 38244585
[TBL] [Abstract][Full Text] [Related]
13. TMPO-AS1, a Novel E2F1-Regulated lncRNA, Contributes to the Proliferation of Lung Adenocarcinoma Cells via Modulating miR-326/SOX12 Axis.
Wei L; Liu Y; Zhang H; Ma Y; Lu Z; Gu Z; Ding C
Cancer Manag Res; 2020; 12():12403-12414. PubMed ID: 33293866
[TBL] [Abstract][Full Text] [Related]
14. A two-circular RNA signature as a noninvasive diagnostic biomarker for lung adenocarcinoma.
Liu XX; Yang YE; Liu X; Zhang MY; Li R; Yin YH; Qu YQ
J Transl Med; 2019 Feb; 17(1):50. PubMed ID: 30777071
[TBL] [Abstract][Full Text] [Related]
15. Over-Expression of Long Non-Coding RNA-AC099850.3 Correlates With Tumor Progression and Poor Prognosis in Lung Adenocarcinoma.
Chen X; Guo J; Zhou F; Ren W; Pu J; Mutti L; Niu X; Jiang X
Front Oncol; 2022; 12():895708. PubMed ID: 35646670
[TBL] [Abstract][Full Text] [Related]
16. Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for lung adenocarcinoma.
Gao L; Zhang L
BMC Cancer; 2021 Jul; 21(1):849. PubMed ID: 34301211
[TBL] [Abstract][Full Text] [Related]
17. Identification of a competing endogenous RNA axis "SVIL-AS1/miR-103a/ICE1" associated with chemoresistance in lung adenocarcinoma by comprehensive bioinformatics analysis.
Guo L; Ding L; Tang J
Cancer Med; 2021 Sep; 10(17):6022-6034. PubMed ID: 34264003
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
[TBL] [Abstract][Full Text] [Related]
19. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
[TBL] [Abstract][Full Text] [Related]
20. Identification and Validation of lncRNA-AC087588.2 in Lung Adenocarcinoma: A Novel Prognostic and Diagnostic Indicator.
Jiang X; Chen X; Guo J; Zhou F; Pu J; Mutti L; Niu X
Front Mol Biosci; 2022; 9():923584. PubMed ID: 35769906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
